亚星化学(600319) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was CNY 198,954,956.86, representing a 5.61% increase compared to CNY 188,382,789.11 in the same period last year[4] - The net profit attributable to shareholders was a loss of CNY 46,045,120.88, compared to a loss of CNY 35,116,984.16 in the previous year, indicating a worsening performance[4] - The total profit for Q1 2025 was -46.22 million RMB, a decrease of 10.89 million RMB compared to the previous year[12] - Net loss for Q1 2025 was CNY -46,215,150.84, compared to a net loss of CNY -35,368,169.89 in Q1 2024, representing a decline of 30.5%[19] - Total operating costs for Q1 2025 were CNY 245,272,170.03, up 8.9% from CNY 225,092,929.54 in Q1 2024[18] Cash Flow - The net cash flow from operating activities was negative at CNY -70,008,625.04, a significant decline from CNY -12,933,392.44 in the previous year[4] - Cash flow from operating activities for Q1 2025 was CNY -70,008,625.04, worsening from CNY -12,933,392.44 in Q1 2024[21] - The net cash flow from financing activities for Q1 2025 was CNY 30,282,854.85, compared to CNY 15,875,547.87 in Q1 2024, an increase of 90.5%[23] - The company has seen a 90.75% increase in cash flow from financing activities due to new financing compared to the previous year[7] Assets and Liabilities - Total assets increased by 8.67% to CNY 2,591,135,149.26 from CNY 2,384,490,644.30 at the end of the previous year[5] - The company's total equity decreased to CNY 505,327,714.68 in Q1 2025 from CNY 551,542,865.52 in Q1 2024, a decline of 8.4%[16] - Total liabilities increased to CNY 2,085,807,434.58 in Q1 2025 from CNY 1,832,947,778.78 in Q1 2024, marking an increase of 13.8%[16] - The company's equity attributable to shareholders decreased by 8.42% to CNY 500,801,089.36 from CNY 546,846,210.24 at the end of the previous year[5] Inventory and Receivables - Accounts receivable increased by 28.96% due to higher sales compared to the same period last year[7] - The company reported a decrease in accounts receivable from 68.65 million RMB to 53.24 million RMB year-on-year[14] - Inventory rose by 32.56% as raw material stock increased compared to the beginning of the period[7] - The inventory level increased to 155.12 million RMB from 117.02 million RMB year-on-year[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 16,235[9] Projects and Developments - The company is progressing on a high-end new materials project with an expected operational date in Q3 2025, with construction of public engineering facilities ongoing[11] - The hydrogen production project using the hydrogen peroxide method is on track for completion within the year, with the industrial design proceeding as planned[11] - The company is currently in the peak installation phase for two projects, each with a capacity of 500 tons/year, expected to be operational by Q3 2025[11] Borrowings and Financial Expenses - The company raised CNY 606,900,000.00 in borrowings during Q1 2025, significantly higher than CNY 277,375,000.00 in Q1 2024[21] - The company incurred financial expenses of CNY 22,327,238.38 in Q1 2025, compared to CNY 21,111,057.95 in Q1 2024, an increase of 5.7%[19] - The company's short-term borrowings were reported at 770.16 million RMB, slightly down from 774.83 million RMB at the end of 2024[15]